Mental Health Care Company COMPASS Pathways Concludes Successful Series B Investment Round
London (ots/PRNewswire) - $80m Raised Will Further the Development of Psilocybin Therapy COMPASS Pathways, a mental health care company, announced today that it has completed a successful $80m Series B investment round. This funding will expand upon COMPASS's lead programme in psilocybin therapy for treatment-resistant depression, supporting research into additional ...